These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35222010)

  • 1. Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines.
    Kolaczynska KE; Luethi D; Trachsel D; Hoener MC; Liechti ME
    Front Pharmacol; 2021; 12():794254. PubMed ID: 35222010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines.
    Kolaczynska KE; Luethi D; Trachsel D; Hoener MC; Liechti ME
    Front Pharmacol; 2019; 10():1423. PubMed ID: 31849671
    [No Abstract]   [Full Text] [Related]  

  • 3. Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs).
    Rickli A; Luethi D; Reinisch J; Buchy D; Hoener MC; Liechti ME
    Neuropharmacology; 2015 Dec; 99():546-53. PubMed ID: 26318099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs).
    Luethi D; Trachsel D; Hoener MC; Liechti ME
    Neuropharmacology; 2018 May; 134(Pt A):141-148. PubMed ID: 28720478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
    Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
    J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine receptor interaction profiles of 4-aryl-substituted 2,5-dimethoxyphenethylamines (2C-BI derivatives).
    Luethi D; Widmer R; Trachsel D; Hoener MC; Liechti ME
    Eur J Pharmacol; 2019 Jul; 855():103-111. PubMed ID: 31063768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Bulky
    Soares BA; Yempala T; Martínez-Afani D; Acevedo-Fuentes W; Brea J; Loza MI; Cimadevila M; Cassels BK
    ACS Chem Neurosci; 2024 Feb; 15(3):608-616. PubMed ID: 38241462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors.
    Nelson DL; Lucaites VL; Wainscott DB; Glennon RA
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):1-6. PubMed ID: 9933142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pharmacology and ligand docking studies reveal a single amino acid difference between mouse and human serotonin 5-HT2A receptors that impacts behavioral translation of novel 4-phenyl-2-dimethylaminotetralin ligands.
    Canal CE; Cordova-Sintjago T; Liu Y; Kim MS; Morgan D; Booth RG
    J Pharmacol Exp Ther; 2013 Dec; 347(3):705-16. PubMed ID: 24080681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function.
    Eshleman AJ; Forster MJ; Wolfrum KM; Johnson RA; Janowsky A; Gatch MB
    Psychopharmacology (Berl); 2014 Mar; 231(5):875-88. PubMed ID: 24142203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple O-acylated derivatives of lysergol and dihydrolysergol-I: synthesis and interaction with 5-HT2A, 5-HT2C and 5-HT1B receptors, and alpha1 adrenergic receptors.
    Pertz HH; Brown AM; Gager TL; Kaumann AJ
    J Pharm Pharmacol; 1999 Mar; 51(3):319-30. PubMed ID: 10344634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
    Rickli A; Moning OD; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding and functional structure-activity similarities of 4-substituted 2,5-dimethoxyphenyl isopropylamine analogues at 5-HT
    Hemanth P; Nistala P; Nguyen VT; Eltit JM; Glennon RA; Dukat M
    Front Pharmacol; 2023; 14():1101290. PubMed ID: 36762110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
    Moya PR; Berg KA; Gutiérrez-Hernandez MA; Sáez-Briones P; Reyes-Parada M; Cassels BK; Clarke WP
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1054-61. PubMed ID: 17337633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of 3,4-methylenedioxyamphetamine (MDA) analogs and two amphetamine-based compounds: N,α-DEPEA and DPIA.
    Kolaczynska KE; Ducret P; Trachsel D; Hoener MC; Liechti ME; Luethi D
    Eur Neuropsychopharmacol; 2022 Jun; 59():9-22. PubMed ID: 35378384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice.
    Halberstadt AL; Chatha M; Chapman SJ; Brandt SD
    J Psychopharmacol; 2019 Mar; 33(3):406-414. PubMed ID: 30789291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.
    Newton RA; Phipps SL; Flanigan TP; Newberry NR; Carey JE; Kumar C; McDonald B; Chen C; Elliott JM
    J Neurochem; 1996 Dec; 67(6):2521-31. PubMed ID: 8931486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists.
    Hansen M; Phonekeo K; Paine JS; Leth-Petersen S; Begtrup M; Bräuner-Osborne H; Kristensen JL
    ACS Chem Neurosci; 2014 Mar; 5(3):243-9. PubMed ID: 24397362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus.
    Fiorino F; Severino B; De Angelis F; Perissutti E; Magli E; Frecentese F; Esposito A; Massarelli P; Nencini C; Viti B; Santagada V; Caliendo G
    Pharmazie; 2009 Sep; 64(9):555-64. PubMed ID: 19827295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.